|
Clinical
PhysOrg.com - latest science and technology news:
(PhysOrg.com) -- Clinical trials comparing a spray-on skin product with skin grafts will start in the US in December. The trials, which are partly funded by a US army grant of $1.4 million, will last about a year and will inv (Read More)
News Network:
Medicine Today
Respiratory / Asthma News From Medical News Today:
Key points: - The clinical consultation rate for influenza - not necessarily swine flu - in Wales during the week ending 15 November decreased to 36.0 cases of flu-like illness diagnosed by GPs out of every 100,000 people (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the Amer (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Pharmasset, Inc. (Nasdaq: VRUS) announced that the enrollment of Cohort 2, led by its partner Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY), will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b tria (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmith (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation. The AVG study repr (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic (Read More)
News Network:
Medicine Today
Topic:
Research
Clinical Trials / Drug Trials News From Medical News Today:
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinop (Read More)
News Network:
Medicine Today
Topic:
Treatment
Clinical Cases and Images - Blog:
Occupational ExposureThe rate of HIV transmission through percutaneous inoculation (i.e., a needle or other instrument that pierces the skin) is 0.3%.Splashes of infectious material to mucous membranes (e.g., conjunctivae or (Read More)
News Network:
Medicine Today
Clinical Cases and Images - Blog:
From the NYTimes:30 million men in U.S. experience erectile dysfunction (ED), 30% of men in their 50s, more than 50% of those in their 60s.One Viagra pill, the most common way to treat erection problems, costs about $15. Viag (Read More)
News Network:
Medicine Today
Immune System / Vaccines News From Medical News Today:
Scientists of Helmholtz Zentrum München and the Center of Allergy and Environment (ZAUM) of Technische Universität München have discovered a new type of immune cells - the Th22 cells - which can protect the body against in (Read More)
News Network:
Medicine Today
Topics:
Inflammation,
Chronic
Health News from Medical News Today:
A pediatric immunologist at The Children's Hospital of Philadelphia has received a prestigious annual award from the American Philosophical Society, an organization founded in 1743 by Benjamin Franklin. Jordan S. Orange, M.D. (Read More)
News Networks:
Medicine Today,
Massage Therapy News And Insights
Clinical Trials / Drug Trials News From Medical News Today:
Novartis announced new interim data from ongoing clinical trials demonstrating that a single 7.5µg dose of the company's influenza A(H1N1) 2009 unadjuvanted vaccine, half of the currently-approved US dose, fulfilled immune r (Read More)
News Network:
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) announced today it has been advised by the Data Safety Monitoring Board ("DSMB") that a regularly scheduled safety analysis has been completed and the DS (Read More)
News Network:
Medicine Today
Topic:
Stem Cell
Health News from Medical News Today:
Geron Corporation (Nasdaq:GERN) announced the presentation of interim data from its ongoing trial of imetelstat (GRN163L), a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI- (Read More)
News Networks:
Current Medical News,
Medicine Today
Clinical Trials / Drug Trials News From Medical News Today:
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the (Read More)
News Network:
Medicine Today
Topic:
Therapy
Transplants / Organ Donations News From Medical News Today:
Sleep apnea is common in individuals who receive a kidney transplant and is associated with increased risk of high blood pressure, heart disease or stroke, according to a study appearing in an upcoming issue of the Clinical J (Read More)
News Network:
Medicine Today
Topics:
Disease,
Transplant
Stem Cell Research News From Medical News Today:
Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem (Read More)
News Network:
Medicine Today
Add something
|
||
|
|
||
